Roberto Sosa Hernández

Rituximab in the management of chronic immune thrombocytopenic purpura: an effective and safe therapeutic alternative in refractory patients

Francisco Javier Peñalver, Víctor Jiménez‐Yuste, Manuel Almagro et al. · Annals of Hematology · 2006 · 82 citations

Life Sciences, Hematology, Immunology +10

Clinical variability of patients with the t(6;8)(q27;p12) and FGFR1OP-FGFR1 fusion: two further cases

J.L. Vizmanos, Roberto Sosa Hernández, María Vidal et al. · The Hematology Journal · 2004 · 55 citations

Medicine, Oncology, Cancer Genetics +6

Amplification of <i>IGH/MYC</i> fusion in clinically aggressive <i>IGH/BCL2</i>‐positive germinal center B‐cell lymphomas

José I. Martín‐Subero, María D. Odero, Roberto Sosa Hernández et al. · Genes Chromosomes and Cancer · 2005 · 47 citations

Medicine, Hematology, Oncology +17

MicroRNA-21 predicts response to preoperative chemoradiotherapy in locally advanced rectal cancer

Cristina Caramés, Ion Cristóbal, Víctor Moreno et al. · International Journal of Colorectal Disease · 2015 · 47 citations

Medicine, Oncology, Surgery +14

6q deletion in Waldenström macroglobulinaemia negatively affects time to transformation and survival

Ramón García‐Sánz, Irene Dogliotti, Gian Maria Zaccaria et al. · British Journal of Haematology · 2020 · 47 citations · Full text

Life Sciences, Genetics, Hematology +17